These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 26340897

  • 1. Aggressive giant cell lesion of the jaws: a review of management options and report of a mandibular lesion treated with denosumab.
    O'Connell JE, Bowe C, Murphy C, Toner M, Kearns GJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):e191-8. PubMed ID: 26340897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

  • 6. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH.
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R.
    World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843
    [Abstract] [Full Text] [Related]

  • 12. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA.
    Hum Pathol; 2017 May 04; 63():89-97. PubMed ID: 28235628
    [Abstract] [Full Text] [Related]

  • 13. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
    Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS.
    J Orthop Sci; 2018 May 04; 23(3):570-577. PubMed ID: 29429890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Giant cell tumor of bone under Denosumab treatment.
    Wendling D, Guillot X, Sondag M, Chaigneau L, Aubry S, Prati C.
    Joint Bone Spine; 2018 Jul 04; 85(4):491. PubMed ID: 28970075
    [No Abstract] [Full Text] [Related]

  • 19. A novel approach to the management of a central giant cell granuloma with denosumab: A case report and review of current treatments.
    Gupta B, Stanton N, Coleman H, White C, Singh J.
    J Craniomaxillofac Surg; 2015 Sep 04; 43(7):1127-32. PubMed ID: 26032758
    [Abstract] [Full Text] [Related]

  • 20. Management of central giant cell granuloma with subcutaneous denosumab therapy.
    Naidu A, Malmquist MP, Denham CA, Schow SR.
    J Oral Maxillofac Surg; 2014 Dec 04; 72(12):2469-84. PubMed ID: 25262402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.